Dimensional Fund Advisors LP Invests $3.65 Million in Lantheus Holdings, Inc. (LNTH)
Dimensional Fund Advisors LP acquired a new position in Lantheus Holdings, Inc. (NASDAQ:LNTH) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 291,684 shares of the medical equipment provider’s stock, valued at approximately $3,646,000. Dimensional Fund Advisors LP owned approximately 0.79% of Lantheus Holdings at the end of the most recent reporting period.
Other institutional investors also recently added to or reduced their stakes in the company. Monashee Investment Management LLC bought a new position in Lantheus Holdings during the first quarter worth $5,313,000. Laurion Capital Management LP bought a new position in Lantheus Holdings during the first quarter worth $3,422,000. Spark Investment Management LLC raised its position in Lantheus Holdings by 129.0% in the first quarter. Spark Investment Management LLC now owns 300,900 shares of the medical equipment provider’s stock worth $3,761,000 after buying an additional 169,500 shares during the period. Mckinley Capital Management LLC Delaware raised its position in Lantheus Holdings by 109.4% in the first quarter. Mckinley Capital Management LLC Delaware now owns 281,221 shares of the medical equipment provider’s stock worth $3,515,000 after buying an additional 146,936 shares during the period. Finally, Systematic Financial Management LP bought a new position in Lantheus Holdings during the first quarter worth $1,314,000. 84.35% of the stock is currently owned by institutional investors.
Lantheus Holdings, Inc. (LNTH) traded up 1.48% during trading on Wednesday, reaching $17.15. The company’s stock had a trading volume of 244,905 shares. The company has a market capitalization of $640.55 million, a PE ratio of 23.43 and a beta of 0.91. The company has a 50 day moving average price of $17.79 and a 200-day moving average price of $14.77. Lantheus Holdings, Inc. has a 52 week low of $7.18 and a 52 week high of $20.45.
Lantheus Holdings (NASDAQ:LNTH) last announced its earnings results on Tuesday, August 1st. The medical equipment provider reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.18. Lantheus Holdings had a net margin of 8.44% and a negative return on equity of 37.47%. The company had revenue of $88.83 million for the quarter, compared to the consensus estimate of $80.56 million. During the same period in the previous year, the business earned $0.24 EPS. The company’s revenue was up 13.9% on a year-over-year basis. Equities research analysts anticipate that Lantheus Holdings, Inc. will post $1.12 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: This story was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/08/30/dimensional-fund-advisors-lp-invests-3-65-million-in-lantheus-holdings-inc-lnth.html.
LNTH has been the topic of a number of recent research reports. Cantor Fitzgerald initiated coverage on Lantheus Holdings in a research note on Monday, July 17th. They set an “overweight” rating and a $22.00 price objective on the stock. Zacks Investment Research raised Lantheus Holdings from a “hold” rating to a “strong-buy” rating and set a $17.00 price objective on the stock in a research note on Thursday, May 4th. Jefferies Group LLC boosted their price objective on Lantheus Holdings from $15.00 to $18.00 and gave the stock a “buy” rating in a research note on Wednesday, May 3rd. Credit Suisse Group boosted their price objective on Lantheus Holdings from $14.00 to $19.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 2nd. Finally, BidaskClub lowered Lantheus Holdings from a “strong-buy” rating to a “buy” rating in a research note on Thursday, August 17th. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $18.60.
In other Lantheus Holdings news, insider Michael P. Duffy sold 20,000 shares of the business’s stock in a transaction on Monday, June 12th. The shares were sold at an average price of $15.42, for a total transaction of $308,400.00. Following the sale, the insider now directly owns 188,234 shares of the company’s stock, valued at approximately $2,902,568.28. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Mary Anne Heino sold 10,000 shares of the business’s stock in a transaction on Monday, June 12th. The shares were sold at an average price of $15.39, for a total transaction of $153,900.00. Following the sale, the chief executive officer now directly owns 602,468 shares in the company, valued at $9,271,982.52. The disclosure for this sale can be found here. Over the last three months, insiders have sold 3,412,858 shares of company stock worth $51,668,555. Company insiders own 2.30% of the company’s stock.
Lantheus Holdings Company Profile
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Want to see what other hedge funds are holding LNTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lantheus Holdings, Inc. (NASDAQ:LNTH).
Receive News & Stock Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related stocks with our FREE daily email newsletter.